The use of Hydroxychloroquine in the Treatment of COVID-19

被引：1

作者：

Tecen-Yucel, Kamer ^{[1
]}

Kara, Emre ^{[1
]}

Demirkan, Kutay ^{[1
]}

Unal, Serhat ^{[2
]}

机构：

[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, Ankara, Turkey

[2] Hacettepe Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Ankara, Turkey

来源：

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2020年 / 25卷 / 03期

关键词：

Hydroxychloroquine; COVID-19; VIRAL-INFECTIONS; CHLOROQUINE; PHARMACOKINETICS;

D O I：

10.5578/flora.69845

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

COVID-19 is a newly emerging human infectious disease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) origin described as a pandemic by the World Health Organisation (WHO) on March 11, 2020. There is currently no definitive cure for COVID-19; however, among the many treatment strategies, hydroxychloroquine has been suggested as a potential treatment. The purpose of this article was to review the pharmacological properties and mechanism of COVID-19 treatment with hydroxychloroquine and its potential use on the current COVID-19 pandemic.

引用

页码：283 / 291

页数：9

共 50 条

[31] Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19
Albariqi, Ahmed H.
Chang, Rachel Yoon Kyung
Tai, Waiting
Ke, Wei-Ren
Chow, Michael Y. T.
Tang, Patricia
Kwok, Philip Chi Lip
Chan, Hak-Kim
[J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (01) : 20 - 31
[32] Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
Li Zou
Lijun Dai
Xingyu Zhang
Zhaohui Zhang
Zhentao Zhang
[J]. Archives of Pharmacal Research, 2020, 43 : 765 - 772
[33] Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19
Piszczatoski, Christopher R.
Powell, Jason
[J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 827 - 831
[34] Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
El Ouarradi, Amal
Abdeladim, Salma
Oualim, Sara
Filali, Rita Aniq
Bensahi, Ilham
Elharass, Mahassine
Hafid, Sara
Tazi, Hamza
Naitlhou, Abdelhamid
Bouaiti, El Arbi
Moustaghfir, Abdelhamid
Sabry, Mohamed
[J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2020, 32 (03) : 350 - 357
[35] Chloroquine and hydroxychloroquine in covid-19
Ferner, Robin E.
Aronson, Jeffrey K.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
[36] Hydroxychloroquine and COVID-19: The endgame!
Deplanque, Dominique
[J]. THERAPIE, 2023, 78 (04): : 343 - 344
[37] Hydroxychloroquine and Covid-19 saga
Gocko, Xavier
Tudrej, Benoit
Fintz, Axel
Plotton, Catherine
Boussageon, Remy
Pouchain, Denis
[J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (173): : 224 - 229
[38] Hydroxychloroquine in COVID-19 widespread use despite unproven benefit
Ish, Pranav
[J]. INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (02) : 213 - 213
[39] Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
Stevenson, Alex
Kirresh, Ali
Conway, Samuel
White, Laura
Ahmad, Mahmood
Little, Callum
[J]. OPEN HEART, 2020, 7 (02):
[40] Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
Kara, Emre
Demirkan, Kutay
Unal, Serhat
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)

← 1 2 3 4 5 →